ATE195516T1 - Substituierte phenylverbindungen als endothelinantagoniste - Google Patents

Substituierte phenylverbindungen als endothelinantagoniste

Info

Publication number: ATE195516T1
Authority: AT; Austria
Prior art keywords: aryl; heteroaryl; optionally substituted; substituted phenyl; compounds
Prior art date: 1995-01-27

Application number

AT96900634T

Other languages

English (en)

Inventor

Barry Porter

Christopher Smith

Roger John Aitchison Walsh

South Road

Tahir Nadeem Majid

Clive Mccarthy

Neil Victor Harris

Peter Charles Astles

Iain Mcfarlane Mclay

Andrew David Morley

Frank Halley

Andrew William Bridge

Sickle Andrew Paul Van

Original Assignee

Rhone Poulenc Rorer Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-01-27

Filing date

1996-01-22

Publication date

2000-09-15

1995-01-27 Priority claimed from GBGB9501635.8A external-priority patent/GB9501635D0/en

1995-03-01 Priority claimed from GBGB9504061.4A external-priority patent/GB9504061D0/en

1995-05-11 Priority claimed from GBGB9509604.6A external-priority patent/GB9509604D0/en

1996-01-22 Application filed by Rhone Poulenc Rorer Ltd filed Critical Rhone Poulenc Rorer Ltd

2000-09-15 Application granted granted Critical

2000-09-15 Publication of ATE195516T1 publication Critical patent/ATE195516T1/de

Links

-1 PHENYL COMPOUNDS Chemical class 0.000 title 1
239000005557 antagonist Substances 0.000 title 1
125000001072 heteroaryl group Chemical group 0.000 abstract 4
125000003118 aryl group Chemical group 0.000 abstract 3
125000003545 alkoxy group Chemical group 0.000 abstract 2
125000004414 alkyl thio group Chemical group 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
150000001204 N-oxides Chemical class 0.000 abstract 1
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
239000005864 Sulphur Chemical group 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
239000002308 endothelin receptor antagonist Substances 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical class 0.000 abstract 1
229910052760 oxygen Inorganic materials 0.000 abstract 1
239000001301 oxygen Substances 0.000 abstract 1
239000000651 prodrug Substances 0.000 abstract 1
229940002612 prodrug Drugs 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
125000003107 substituted aryl group Chemical group 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/08—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/12—Radicals substituted by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/54—Radicals substituted by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pyridine Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)
Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT96900634T 1995-01-27 1996-01-22 Substituierte phenylverbindungen als endothelinantagoniste ATE195516T1 (de)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GBGB9501635.8A GB9501635D0 (en)	1995-01-27	1995-01-27	Chemical compounds
GBGB9504061.4A GB9504061D0 (en)	1995-03-01	1995-03-01	Chemical compounds
GBGB9509604.6A GB9509604D0 (en)	1995-05-11	1995-05-11	Chemical compounds
PCT/GB1996/000120 WO1996022978A1 (en)	1995-01-27	1996-01-22	Substituted phenyl compounds as endothelin antagonists

Publications (1)

Publication Number	Publication Date
ATE195516T1 true ATE195516T1 (de)	2000-09-15

Family

ID=27267564

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT96900634T ATE195516T1 (de)	1995-01-27	1996-01-22	Substituierte phenylverbindungen als endothelinantagoniste

Country Status (18)

Country	Link
EP (1)	EP0805802B1 (de)
JP (1)	JP3901729B2 (de)
KR (1)	KR19980701690A (de)
AT (1)	ATE195516T1 (de)
AU (1)	AU706940B2 (de)
BR (1)	BR9606961A (de)
CA (1)	CA2211646C (de)
CZ (1)	CZ223697A3 (de)
DE (1)	DE69609812D1 (de)
EA (1)	EA000061B1 (de)
FI (1)	FI973111A7 (de)
HU (1)	HUP9801938A3 (de)
IL (1)	IL116907A0 (de)
MX (1)	MX9705649A (de)
NO (1)	NO973441L (de)
NZ (1)	NZ298853A (de)
PL (1)	PL184060B1 (de)
WO (1)	WO1996022978A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6030975A (en) *	1997-03-14	2000-02-29	Basf Aktiengesellschaft	Carboxylic acid derivatives, their preparation and use in treating cancer
ES2214734T3 (es) *	1997-09-26	2004-09-16	ABBOTT GMBH & CO. KG	Antagonista de la endotelina e inhibidor del sistema renina-angiotensina como preparado de combinacion.
DE19743142A1 (de) *	1997-09-30	1999-04-01	Knoll Ag	Pharmazeutische Kombinationspräparate
DE19743143A1 (de) *	1997-09-30	1999-04-01	Knoll Ag	Pharmazeutische Kombinationspräparate
WO1999048530A1 (en) *	1998-03-23	1999-09-30	Merck & Co., Inc.	Combination therapy for the treatment of benign prostatic hyperplasia
US6410554B1 (en)	1998-03-23	2002-06-25	Merck & Co., Inc.	Combination therapy for the treatment of benign prostatic hyperplasia
US8168616B1 (en)	2000-11-17	2012-05-01	Novartis Ag	Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
US20050165041A1 (en) *	2002-05-07	2005-07-28	Altana Pharma Ag	Combination for the treatment of airway disorders
RS95304A (sr) *	2002-05-07	2006-12-15	Altana Pharma Ag.	Nova kombinacija za tretman oboljenja disajnih puteva

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT617001E (pt) *	1993-03-19	2000-06-30	Merck & Co Inc	Derivados do acido fenoxifenilacetico

1996
- 1996-01-22 PL PL96321545A patent/PL184060B1/pl unknown
- 1996-01-22 EP EP96900634A patent/EP0805802B1/de not_active Expired - Lifetime
- 1996-01-22 BR BR9606961A patent/BR9606961A/pt unknown
- 1996-01-22 CZ CZ972236A patent/CZ223697A3/cs unknown
- 1996-01-22 JP JP52270896A patent/JP3901729B2/ja not_active Expired - Lifetime
- 1996-01-22 KR KR1019970705086A patent/KR19980701690A/ko not_active Withdrawn
- 1996-01-22 HU HU9801938A patent/HUP9801938A3/hu unknown
- 1996-01-22 DE DE69609812T patent/DE69609812D1/de not_active Expired - Lifetime
- 1996-01-22 AU AU44541/96A patent/AU706940B2/en not_active Expired
- 1996-01-22 AT AT96900634T patent/ATE195516T1/de not_active IP Right Cessation
- 1996-01-22 WO PCT/GB1996/000120 patent/WO1996022978A1/en not_active Ceased
- 1996-01-22 CA CA002211646A patent/CA2211646C/en not_active Expired - Lifetime
- 1996-01-22 NZ NZ298853A patent/NZ298853A/en unknown
- 1996-01-22 EA EA199700147A patent/EA000061B1/ru not_active IP Right Cessation
- 1996-01-25 IL IL11690796A patent/IL116907A0/xx unknown
1997
- 1997-07-25 FI FI973111A patent/FI973111A7/fi unknown
- 1997-07-25 NO NO973441A patent/NO973441L/no unknown
- 1997-07-25 MX MX9705649A patent/MX9705649A/es unknown

Also Published As

Publication number	Publication date
AU4454196A (en)	1996-08-14
NZ298853A (en)	1998-07-28
PL321545A1 (en)	1997-12-08
NO973441D0 (no)	1997-07-25
EA199700147A1 (ru)	1997-12-30
HUP9801938A2 (hu)	1999-05-28
EA000061B1 (ru)	1998-04-30
KR19980701690A (ko)	1998-06-25
HUP9801938A3 (en)	1999-10-28
FI973111A7 (fi)	1997-09-25
NO973441L (no)	1997-09-15
CZ223697A3 (en)	1997-12-17
FI973111A0 (fi)	1997-07-25
IL116907A0 (en)	1996-05-14
EP0805802B1 (de)	2000-08-16
DE69609812D1 (de)	2000-09-21
MX9705649A (es)	1998-07-31
BR9606961A (pt)	1997-11-04
AU706940B2 (en)	1999-07-01
WO1996022978A1 (en)	1996-08-01
EP0805802A1 (de)	1997-11-12
CA2211646C (en)	2008-09-09
PL184060B1 (pl)	2002-08-30
JPH10513158A (ja)	1998-12-15
CA2211646A1 (en)	1996-08-01
JP3901729B2 (ja)	2007-04-04

Legal Events

Date	Code	Title	Description
2001-01-15	UEP	Publication of translation of european patent specification
2004-10-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE37375T1 (de)	1988-10-15	Phosphonyl-hydroxyacyl-aminosaeure-derivate und ihre verwendung als antihypertensiva.
NO965125L (no)	1997-06-02	Heterosykliske forbindelser med tachykininreseptor-antagonistaktivitet, deres fremstilling og anvendelse
ATE239477T1 (de)	2003-05-15	Chinolone und deren therapeutische verwendung
ATE219764T1 (de)	2002-07-15	Zimtsäurederivate und deren verwendung als integrin-antagonisten
DE60023318D1 (de)	2006-03-02	Heteropolycyclische verbindungen und ihre verwendung als antagonisten von metabotropen glutamatrezeptoren
DE69837346D1 (de)	2007-04-26	Anilidderivate, deren herstellung und verwendung
DE69527072D1 (de)	2002-07-18	Endothelin antagoniste
ATE227277T1 (de)	2002-11-15	Isoxazoline derivate und ihre verwendung als antimikroben
ATE481103T1 (de)	2010-10-15	Derivate von 2-(8,9-dioxo-2,6- diazabicyclo(5.2.0)non-1(7)-en-2- yl)alkylphosphonsäure und deren verwendung als n- methyl-d-aspartat- (nmda-) rezeptorantagonisten
CY1105091T1 (el)	2009-11-04	Αντικατεστημενες ενωσεις 2-αρυλοβενζαζολιου και η χρηση τους σαν παραγοντες κατα των ογκων
TR200000025T2 (tr)	2000-06-21	Azetidinilpropilpiperidin türevleri, ara bağlarıyla tacikinin antagonistleri olarak kullanımları.
DE69813605D1 (de)	2003-05-22	Benzofuranderivate
DE69924292D1 (de)	2005-04-21	Pyrazol verbindungen und ihre verwendung
ATE195516T1 (de)	2000-09-15	Substituierte phenylverbindungen als endothelinantagoniste
DE59909760D1 (de)	2004-07-22	Benzonaphthyridin-n-oxide mit pde3 und pde4 inhibierender aktivität
TR200000786T2 (tr)	2000-08-21	Vitronektin reseptör antagonisti
TR200000721T2 (tr)	2000-11-21	Vitronektin reseptör antagonistleri.
ATE287886T1 (de)	2005-02-15	Verwendung von 5-thio, sulfinyl- und sulfonylpyrazolo 3,4-b) pyridinen als cyclin- abhängige kinase-hemmer
ATE384049T1 (de)	2008-02-15	Therapeutische heterocyclen als bradykinin b2 rezeptor antagonisten
ATE374189T1 (de)	2007-10-15	Phthalazinon-derivate als pde 4 hemmer
ATE234098T1 (de)	2003-03-15	4-aminopyrrole (3,2-d) pyrimidinen als antagonisten des neuropeptide y receptors
DE69526097D1 (de)	2002-05-02	Bicyclische carboxamide als 5-ht1a rezeptoren liganden
PT1104419E (pt)	2002-09-30	Derivados de azabicicloheptano substituidos no azoto sua preparacao e utilizacao
ATE286892T1 (de)	2005-01-15	Hydroxam- und carbonsäurederivate mit mmp- und tnf-hemmender aktivität
TR200001365T2 (tr)	2000-09-21	Yeni heterosiklik ikame edilmiş a-hidroksikarbonik asit türevleri